+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Upstream Bioprocessing Market by Product, Workflow, Use Type, Mode - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast 2023-2030

  • PDF Icon

    Report

  • 197 Pages
  • July 2023
  • Region: Global
  • 360iResearch™
  • ID: 5612832
UP TO OFF until Dec 31st 2023
1h Free Analyst Time

Quick Summary:

Navigating the intricate landscape of the Global Upstream Bioprocessing Market, a crucial sector with a forecast to reach USD 26.03 billion by 2030, can often be challenging for today's business leaders. This expansive growth potential calls for a precise, grounded understanding of market trends and dynamics. Our in-depth market research report offers a unique blend of qualitative analysis and quantitative data, giving you a comprehensive overview and revealing both hidden opportunities and potential obstacles.

Our report dissects the market based on product, workflow, use type, and mode, offering layered insights that allow you to understand the market with greater precision. A thorough regional analysis across the Americas, Asia-Pacific, and Europe, Middle East & Africa simplifies the complexities of various geographical markets, helping you to make informed business decisions. Detailed market statistics illuminate the competitive landscape, providing you with a robust understanding of vendor contributions, market share, and more. Equip yourself with the information you need to outpace competition by investing in our Global Upstream Bioprocessing Market report today.

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Global Upstream Bioprocessing Market size was estimated at USD 9.47 billion in 2022, USD 10.70 billion in 2023, growing at a CAGR of 13.47% to reach USD 26.03 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Upstream Bioprocessing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Upstream Bioprocessing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

  • Based on Product, the market is studied across Bags & Containers, Bioreactors & Fermenters, Bioreactors Accessories, Cell Culture Products, and Filters. The Cell Culture Products is projected to witness significant market share during forecast period.
  • Based on Workflow, the market is studied across Cell Culture, Cell Separation, and Media Preparation. The Cell Culture is projected to witness significant market share during forecast period.
  • Based on Use Type, the market is studied across Multi-Use and Single-Use. The Multi-Use is projected to witness significant market share during forecast period.
  • Based on Mode, the market is studied across In-House and Outsourced. The In-House is projected to witness significant market share during forecast period.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Upstream Bioprocessing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

  1. Market Penetration: Provides comprehensive information on the market offered by the key players
  2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
  3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
  5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  1. What is the market size and forecast of the Global Upstream Bioprocessing Market?
  2. What are the inhibiting factors and impact of COVID-19 shaping the Global Upstream Bioprocessing Market during the forecast period?
  3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Upstream Bioprocessing Market?
  4. What is the competitive strategic window for opportunities in the Global Upstream Bioprocessing Market?
  5. What are the technology trends and regulatory frameworks in the Global Upstream Bioprocessing Market?
  6. What is the market share of the leading vendors in the Global Upstream Bioprocessing Market?
  7. What modes and strategic moves are considered suitable for entering the Global Upstream Bioprocessing Market?
Frequently Asked Questions about the Global Upstream Bioprocessing Market

What is the estimated value of the Global Upstream Bioprocessing Market?

The Global Upstream Bioprocessing Market was estimated to be valued at $10.7 Billion in 2023.

What is the growth rate of the Global Upstream Bioprocessing Market?

The growth rate of the Global Upstream Bioprocessing Market is 13.4%, with an estimated value of $26.03 Billion by 2030.

What is the forecasted size of the Global Upstream Bioprocessing Market?

The Global Upstream Bioprocessing Market is estimated to be worth $26.03 Billion by 2030.

Who are the key companies in the Global Upstream Bioprocessing Market?

Key companies in the Global Upstream Bioprocessing Market include Boehringer Ingelheim International GmbH, Danaher Corporation, Eppendorf AG, Esco Micro Pte. Ltd, GE Healthcare, Getinge AB, High Purity New England, Lonza Group AG, Meissner Filtration Products, Inc., and Merck KGaA.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Upstream Bioprocessing Market, by Product, 2022 vs 2030
4.3. Upstream Bioprocessing Market, by Workflow, 2022 vs 2030
4.4. Upstream Bioprocessing Market, by Use Type, 2022 vs 2030
4.5. Upstream Bioprocessing Market, by Mode, 2022 vs 2030
4.6. Upstream Bioprocessing Market, by Region, 2022 vs 2030
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising demand for biotherapeutics
5.1.1.2. Growing implementation of process analytical technology (PAT)
5.1.1.3. Rapid adoption of single-use upstream bioprocessing
5.1.2. Restraints
5.1.2.1. High cost of establishing and maintaining an upstream processing unit
5.1.3. Opportunities
5.1.3.1. Increased acceptance and approvals of biosimilars
5.1.3.2. Rising application of upstream process in cell therapy, cell banking, drug discovery, and recombinant proteins
5.1.4. Challenges
5.1.4.1. Limitations to its capabilities related to standard upstream bioprocess monitoring
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization
6. Upstream Bioprocessing Market, by Product
6.1. Introduction
6.2. Bags & Containers
6.3. Bioreactors & Fermenters
6.4. Bioreactors Accessories
6.5. Cell Culture Products
6.6. Filters
7. Upstream Bioprocessing Market, by Workflow
7.1. Introduction
7.2. Cell Culture
7.3. Cell Separation
7.4. Media Preparation
8. Upstream Bioprocessing Market, by Use Type
8.1. Introduction
8.2. Multi-Use
8.3. Single-Use
9. Upstream Bioprocessing Market, by Mode
9.1. Introduction
9.2. In-House
9.3. Outsourced
10. Americas Upstream Bioprocessing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Upstream Bioprocessing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Upstream Bioprocessing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Boehringer Ingelheim International GmbH
14.1.2. Danaher Corporation
14.1.3. Eppendorf AG
14.1.4. Esco Micro Pte. Ltd
14.1.5. GE Healthcare
14.1.6. Getinge AB
14.1.7. High Purity New England
14.1.8. Lonza Group AG
14.1.9. Meissner Filtration Products, Inc.,
14.1.10. Merck KGaA
14.1.11. Rentschler Biopharma SE
14.1.12. Samsung BioLogics
14.1.13. Sartorius AG
14.1.14. Tornado Spectral Systems
14.1.15. Waters Corporation
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. UPSTREAM BIOPROCESSING MARKET RESEARCH PROCESS
FIGURE 2. UPSTREAM BIOPROCESSING MARKET SIZE, 2022 VS 2030
FIGURE 3. UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 5. UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2022 VS 2030 (%)
FIGURE 6. UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2022 VS 2030 (%)
FIGURE 7. UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2022 VS 2030 (%)
FIGURE 8. UPSTREAM BIOPROCESSING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 9. UPSTREAM BIOPROCESSING MARKET DYNAMICS
FIGURE 10. UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 18. UPSTREAM BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 19. UPSTREAM BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. UPSTREAM BIOPROCESSING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 5. UPSTREAM BIOPROCESSING MARKET SIZE, BY BAGS & CONTAINERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. UPSTREAM BIOPROCESSING MARKET SIZE, BY BIOREACTORS & FERMENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. UPSTREAM BIOPROCESSING MARKET SIZE, BY BIOREACTORS ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL CULTURE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. UPSTREAM BIOPROCESSING MARKET SIZE, BY FILTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 11. UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL SEPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA PREPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 15. UPSTREAM BIOPROCESSING MARKET SIZE, BY MULTI-USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. UPSTREAM BIOPROCESSING MARKET SIZE, BY SINGLE-USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 18. UPSTREAM BIOPROCESSING MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. UPSTREAM BIOPROCESSING MARKET SIZE, BY OUTSOURCED, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 33. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 35. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 36. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 37. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 39. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 40. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 55. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 57. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 58. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 59. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 61. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 62. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 67. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 69. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 70. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 91. THAILAND UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. THAILAND UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 93. THAILAND UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 94. THAILAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 104. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 106. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 107. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 108. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 110. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 111. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 112. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 114. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 115. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 116. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 118. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 119. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 120. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 122. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 123. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 128. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 130. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 131. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 140. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 142. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 143. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 144. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 146. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 147. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 148. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 150. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 151. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 164. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 166. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 167. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 176. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 178. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 179. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 188. UPSTREAM BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 189. UPSTREAM BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2022
TABLE 190. UPSTREAM BIOPROCESSING MARKET LICENSE & PRICING

Companies Mentioned

  • Boehringer Ingelheim International GmbH
  • Danaher Corporation
  • Eppendorf AG
  • Esco Micro Pte. Ltd
  • GE Healthcare
  • Getinge AB
  • High Purity New England
  • Lonza Group AG
  • Meissner Filtration Products, Inc.,
  • Merck KGaA
  • Rentschler Biopharma SE
  • Samsung BioLogics
  • Sartorius AG
  • Tornado Spectral Systems
  • Waters Corporation

Methodology

Loading
LOADING...